GNB3 TT Genotype Predicts Enhanced Benefit of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in African Americans with Heart Failure: Results of the A-HeFT Trial
- Resource Type
- Abstract
- Source
- In
Journal of Cardiac Failure 2006 12(6) Supplement:S71-S71 - Subject
- Language
- ISSN
- 1071-9164